Pentacarinat and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Pentacarinat (pentamidine isethionate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Kaletra, and have Hiv infection.

The phase IV clinical study analyzes which people have Dizziness when taking Pentacarinat. It is created by eHealthMe based on reports of 1,546 people who have side effects when taking Pentacarinat from the FDA, and is updated regularly.

What is Pentacarinat?

Pentacarinat has active ingredients of pentamidine isethionate. eHealthMe is studying from 1,546 Pentacarinat users. Check the latest studies of Pentacarinat.

What is Dizziness?

Dizziness is found to be associated with 3,569 drugs and 5,711 conditions by eHealthMe. Check the latest studies of Dizziness.

On Jul, 14, 2026

1,546 people reported to have side effects when taking Pentacarinat.
Among them, 12 people (0.78%) have Dizziness.

Among these 12 people:

How long have people been on Pentacarinat when they have Dizziness? *

What is the gender of people who have Dizziness when taking Pentacarinat? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Dizziness when taking Pentacarinat? *

What are other drugs people take besides Pentacarinat? *

Kaletra: 6 people, 50.00%
Truvada: 5 people, 41.67%
Bactrim: 5 people, 41.67%
Kayexalate: 4 people, 33.33%
Combivir: 4 people, 33.33%
Cordarone: 4 people, 33.33%
Xarelto: 4 people, 33.33%
Paracetamol: 3 people, 25.00%
Valacyclovir Hydrochloride: 2 people, 16.67%
Prednisone: 2 people, 16.67%

What are other side effects people have besides Dizziness? *

Hyperhidrosis (abnormally increased sweating): 6 people, 50.00%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 50.00%
Headache (pain in head): 6 people, 50.00%
Weakness: 5 people, 41.67%
Blood Lactate Dehydrogenase Increased: 4 people, 33.33%
Cough: 4 people, 33.33%
Mediastinum Neoplasm (tumour in mediastinum): 4 people, 33.33%
Itching: 4 people, 33.33%
Tumor Lysis Syndrome: 4 people, 33.33%
Fainting (loss of consciousness and postural tone): 3 people, 25.00%

What are the existing conditions these people have? *

Hiv Infection: 6 people, 50.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 41.67%
Tumor Lysis Syndrome: 4 people, 33.33%
Stable Angina (a constant chest pain): 4 people, 33.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 33.33%
Cardiac Disorder: 4 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Pain: 1 person, 8.33%
Nausea And Vomiting: 1 person, 8.33%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pentacarinat and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pentacarinat:

Pentacarinat (1,546 reports)

Dizziness treatments and more:

Dizziness (613,960 reports)

Browse all side effects of Pentacarinat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,569 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pentamidine isethionate (the active ingredients of Pentacarinat) and Pentacarinat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.